Tranzyme (TZYM -0.4%) says it's completed its chemistry-based drug discovery collaboration with...

|By:, SA News Editor

Tranzyme (TZYM -0.4%) says it's completed its chemistry-based drug discovery collaboration with Bristol-Myers Squibb (BMY +0.1%). TZYM has transferred compounds from the joint research efforts to BMY for further development across multiple drug targets. As such, TZYM will retain the option to further pursue select collaboration targets for internal development.